4-methyl-pentanoic acid {1-[4-guanidino-1-(thiazole-2-carbonyl)-butylcarbamoyl]-2-methyl-propyl}-amide

This compound is a synthetic small molecule with the molecular formula C20H36N6O3S and a molecular weight of approximately 440.6 g/mol[1][3][5]. It belongs to the class of n-acyl-alpha amino acids and derivatives[2]. The structure features a guanidino group, thiazole ring, and multiple amide linkages. There is no evidence that this compound has been approved for any therapeutic use or entered clinical trials beyond preclinical or experimental stages[2]. Its mechanism of action, biological targets, pharmacological activity, and potential indications are not described in public databases as of June 2025. It appears to be an experimental research chemical rather than an established drug.

Other names

N-[(1S)-1-{[(2S)-5-[(diaminomethyl)amino]-1-oxo-1-(1,3-thiazol-2-yl)pentan-2-yl]carbamoyl}-2-methylpropyl]-4-methylpentanamide4-METHYL-PENTANOIC ACID (1-(4-GUANIDINO-1-(THIAZOLE-2-CARBONYL)-BUTYLCARBAMOYL)-2-METHYL-PROPYL)-AMIDEN-((1S)-1–(((2S)–5–((diaminomethyl)amino)–1–oxo–1–(1,3-thiazol–2–yl)pentan–2–yl)carbamoyl)–2–methylpropyl)–4–methylpentanamide